|
Jun 12
|
ASML, Novo Nordisk, Spotify Boast This Sign Of Stock Market Leadership
|
|
Jun 12
|
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
|
|
Jun 12
|
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
|
|
Jun 11
|
Update: Novo Nordisk to Face Senate Panel Subpoena Vote Over Ozempic, Wegovy Prices
|
|
Jun 11
|
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
|
|
Jun 11
|
Here’s Billionaire George Soros’s Favorite Weight Loss Stock
|
|
Jun 11
|
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
|
|
Jun 10
|
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
|
|
Jun 10
|
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
|
|
Jun 10
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Jun 10
|
Macy's and Five Below have been highlighted as Zacks Bull and Bear of the Day
|
|
Jun 10
|
Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock
|
|
Jun 10
|
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, TotalEnergies, U.S. Bancorp and Flanigan's
|
|
Jun 9
|
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
|
|
Jun 8
|
Here's Why Demand for Ozempic and Wegovy Could Soar Even Higher
|
|
Jun 7
|
Top Analyst Reports for Novo Nordisk, TotalEnergies & U.S. Bancorp
|
|
Jun 7
|
ECB Rate Cut Propels European Markets: 3 Must-Watch Stocks
|
|
Jun 1
|
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
|
|
Jun 1
|
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
|
|
Jun 1
|
The ‘hardcore’ scientists shifting the dial on obesity
|